Lung Cancer in Women

This publication has 70 references indexed in Scilit:

• Cancer Statistics, 2004
  CA: A Cancer Journal for Clinicians, 2004
• O-188 Encouraging activity and durable responses demonstrated by the epithelial growth factor receptor-tyrosine kinase inhibitor, Erlotinib (Tarceva TM, OSI774), in patients with advanced bronchioloalveolar (BAC) cell carcinoma
  Lung Cancer, 2003
• Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2003
• Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma
  Cancer, 2001
• HPV Positive Bronchopulmonary Carcinomas in Women with Previous High-grade Cervical Intraepithelial Neoplasia (CIN III)
  Acta Oncologica, 1999
• Human papillomavirus DNA in adenosquamous carcinoma of the lung.
  Journal of Clinical Pathology, 1998
• Human papillomavirus infection is not associated with bronchial carcinoma: evaluation byin situ hybridisation and the polymerase chain reaction
  The Journal of Pathology, 1997
• Human papillomavirus DNA in squamous cell carcinoma of the lung.
  Journal of Clinical Pathology, 1996
• Re: Endocrine Factors and Adenocarcinoma of the Lung in Women
  JNCI Journal of the National Cancer Institute, 1994
• Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
  Nature, 1985